Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects
Open Access
- 4 February 2021
- Vol. 70 (11), 2150-2158
- https://doi.org/10.1136/gutjnl-2020-320723
Abstract
Objective Chronic pancreatitis (CP) is a fibroinflammatory syndrome leading to organ dysfunction, chronic pain, an increased risk for pancreatic cancer and considerable morbidity. Due to a lack of specific biomarkers, diagnosis is based on symptoms and specific but insensitive imaging features, preventing an early diagnosis and appropriate management. Design We conducted a type 3 study for multivariable prediction for individual prognosis according to the TRIPOD guidelines. A signature to distinguish CP from controls (n=160) was identified using gas chromatography-mass spectrometry and liquid chromatography‐tandem mass spectrometry on ethylenediaminetetraacetic acid (EDTA)-plasma and validated in independent cohorts. Results A Naive Bayes algorithm identified eight metabolites of six ontology classes. After algorithm training and computation of optimal cut-offs, classification according to the metabolic signature detected CP with an area under the curve (AUC) of 0.85 ((95% CI 0.79 to 0.91). External validation in two independent cohorts (total n=502) resulted in similar accuracy for detection of CP compared with non-pancreatic controls in EDTA-plasma (AUC 0.85 (95% CI 0.81 to 0.89)) and serum (AUC 0.87 (95% CI 0.81 to 0.95)). Conclusions This is the first study that identifies and independently validates a metabolomic signature in plasma and serum for the diagnosis of CP in large, prospective cohorts. The results could provide the basis for the development of the first routine laboratory test for CP.Keywords
Funding Information
- Bundesministerium für Bildung und Forschung (0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, GANI-MED 03IS2061A)
- Deutsche Krebshilfe (109102)
- Deutsche Forschungsgemeinschaft (BE 6395/1 -1, MA 4115/1-2/3, SFB1321: Project-ID 329628492)
- Wilhelm Sander-Stiftung (2009.039.2)
- FP7 Health (EU-FP-7: EPC-TM)
- state ministry Mecklenburg Vorpommern EFRE (ESF/14-BM-A55-0010/18 EnErGie, ESF/14-BM-A55-0045/16 PePP, V-630-S150-2012/132/133)
This publication has 55 references indexed in Scilit:
- Carotenoid deficiency in chronic pancreatitis: the effect of an increase in tomato consumptionEuropean Journal of Clinical Nutrition, 2010
- Metabolite Profiling Identifies Candidate Markers Reflecting the Clinical Adaptations Associated with Roux-en-Y Gastric Bypass SurgeryPLOS ONE, 2009
- Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: A novel disease mechanismHuman Mutation, 2009
- Trends and forecasts of hospital admissions for acute and chronic pancreatitis in the NetherlandsEuropean Journal of Gastroenterology & Hepatology, 2008
- The use of metabolomics for the discovery of new biomarkers of effectToxicology Letters, 2007
- Carotenol fatty acid esters: easy substrates for digestive enzymes?Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2002
- ABC of diseases of liver, pancreas, and biliary system: Chronic pancreatitisBMJ, 2001
- Longitudinal Analysis Shows Serum Carotenoid Concentrations are Low in Children with Cystic FibrosisJournal of the American Dietetic Association, 1999
- Carotenoids and tocopherols in various hepatobiliary conditionsJournal of Hepatology, 1995
- Enhancement of transforming growth factor β1 expression in the rat pancreas during regeneration from caerulein‐induced pancreatitisEuropean Journal of Clinical Investigation, 1994